欧盟TI-RADS和ACRTI-RADS评分系统在预测甲状腺恶性瘤方面的诊断性能
Hiba-Allah Chatti1, Ibtissem Oueslati1, Aymen Azaiez2
1Department of Endocrinology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
Endocrinology, diabetes & metabolism
|June 16, 2023
概括
美国放射学学院 (ACR) 和欧洲 (EU) 甲状腺成像报告和数据系统 (TI-RADS) 的分类在预测甲状腺结节恶性病症方面表现相似. 这两种系统都有效地分层风险,有助于对甲状腺结节的临床决策.
科学领域:
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 甲状腺结节很常见,区分良性和恶性是非常重要的.
- 像ACR TI-RADS和EU TI-RADS这样的超声波评分系统有助于风险分层.
- 组织学确认仍然是诊断甲状腺结节的黄金标准.
研究的目的:
- 为了比较ACR TI-RADS和EU TI-RADS的诊断性能.
- 评估这些系统在预测甲状腺结节恶性瘤方面的准确性.
- 评估它们在治疗甲状腺结节的临床决策中的有用性.
主要方法:
- 追溯分析了来自156名患者的198个甲状腺结节 (99个恶性,99个良性).
- 将ACR TI-RADS和EU TI-RADS分类应用于所有结节.
- 使用组织学作为参考标准对诊断性能进行比较.
主要成果:
- 超声波的特征,如固体组成,低可热性和微化,与恶性瘤有关.
- 恶性瘤的患病率在两个系统的TI-RADS类别较高时增加.
- 对于5类结节,欧盟TI-RADS显示出比ACRTI-RADS更高的灵敏度 (60%) 和较低的特异性 (82%) (41%的灵敏度,96%的特异性).
- 组合的第4类和第5类显示了可比性能 (欧盟TI-RADS:89%的灵敏度;ACRTI-RADS:86%的灵敏度).
- 在ROC曲线下的面积是相似的 (欧盟TI-RADS:0.81;ACRTI-RADS:0.82).
结论:
- 欧盟TI-RADS和ACRTI-RADS都是评估甲状腺结节恶性瘤风险的有价值工具.
- 这些系统表现出可比的诊断性能,特别是在考虑组合较高风险类别时.
- 这些分类可以帮助临床医生管理甲状腺结节.
更多相关视频
相关概念视频
Receiver Operating Characteristic Plot
285
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
285
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
42
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42


